Paxlovid, anti-viral COVID-19 drug, available to eligible Sask. residents Wednesday
Paxlovid, an oral anti-viral drug used to treat COVID-19, will be available to eligible Saskatchewan residents 18 and over, starting Wednesday, Jan. 26.
Paxlovid is the first Health Canada approved pill used to treat COVID-19.
The pill is meant for those who have already tested positive for COVID-19 and are experiencing symptoms. It is not meant to be taken as a preventative measure.
It is taken twice per day for five days and stops the virus from multiplying in a person’s body.
Paxlovid is only being given to eligible patients through HealthLine 811 referrals. The province is asking those who feel they are eligible to not visit family physicians or a pharmacy to request the medication.
In a release, the province said Paxlovid is only recommended for adults 18 and older who are symptomatic and within five days of developing symptoms, test positive (PCR or rapid test) for mild or moderate COVID-19, do not have any medical conditions that would make treatment inappropriate and meet one of the following criteria: are immunocompromised, regardless of vaccine status, are 55 and older, and not fully vaccinated, or have a medical condition that puts them at high risk and are not fully vaccinated.
The province also wants people to know the treatment is not meant to be a substitute for vaccination, reiterating that vaccines are still the best defense against serious outcomes from COVID-19.
All Saskatchewan residents five and older are now eligible for a COVID-19 vaccine.
CTVNews.ca Top Stories
Three dead, two hospitalized, following collision in Fredericton: police
Three people have died and two have been hospitalized after a speeding car struck a tree and landed on another vehicle in Fredericton Sunday morning.
Amid climate change warnings, Canadians lukewarm on electric vehicles
Amid scientists' warnings that nations need to transition away from fossil fuels to limit climate change, Canadians are still lukewarm on electric vehicles, according to a study conducted by Nanos Research for CTV News.
Montreal man on the hook for thousands of dollars after a feature on his Tesla caused an accident
A Montreal man is warning Tesla drivers about using the Smart Summon feature after his vehicle hit another in a parking lot.
Madonna's biggest-ever concert transforms Rio's Copacabana beach into a massive dance floor
Madonna put on a free concert on Copacabana beach Saturday night, turning Rio de Janeiro's vast stretch of sand into an enormous dance floor teeming with a multitude of her fans.
1 person killed and 23 injured in a bus crash in northern Maryland, police say
One person was killed and 23 others were injured when a bus crashed early Sunday on Interstate 95 in northern Maryland, police said.
Nylander defends Leafs' core after playoff exit, Toronto again picks up the pieces
The Maple Leafs battled back from a 3-1 series deficit against the Boston Bruins with consecutive 2-1 victories - including one that required extra time - in their first-round playoff series to push the club's Original Six rival to the limit before suffering a devastating Game 7 overtime loss.
El Nino weakening doesn't mean cooler temperatures this summer, forecasters say
As Canadians brace themselves for summer temperatures, forecasters say a weakening El Nino cycle doesn’t mean relief from the heat.
‘Love has no boundaries’: Sask. couple in their 90s and 80s get married
Eighty-two-year-old Susan Neufeldt and 90-year-old Ulrich Richter are no spring chickens, but their love blossomed over the weekend with their wedding at Pine View Manor just outside of Rosthern.
Video shows gaggle of geese stopping traffic on Highway 1 near Vancouver
A mother goose and her goslings caused a bit of a traffic jam on a busy stretch of the Trans-Canada Highway near Vancouver Saturday.